Перейти к содержимому
· Дермальные филлеры
SKU 11134

Saypha Filler Lidocaine

In stock
Volume
1 x 1 mL
Laboratory
Croma-Pharma GmbH
Origin
Австрия
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Saypha Filler Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, developed to correct moderate to severe nasolabial folds and for lip augmentation. It is suitable for practitioners and must be placed in the mid to deep dermis or submucosa. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate-buffered at pH 6.7 to 7.3, giving 2.3% sodium hyaluronate (equivalent to 23 mg/mL) with lidocaine HCl 0.3%, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

Ключевые преимущества Saypha Filler Lidocaine

  • Corrects moderate to severe nasolabial folds and augments the lips
  • Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
  • Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
  • Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
  • BDDE cross-linking agent present at 2 ppm or less
  • Steam sterilised in the syringe, which serves as the sterile barrier
  • Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
  • Manufactured by Croma-Pharma in Austria
Основная информация
Бренд SAYPHA
Производитель Croma-Pharma GmbH
Страна происхождения Austria
Сертификация CE marked 0123. The needles supplied are CE marked 0197
Состав Cross-linked sodium hyaluronate 2.3%, equivalent to 23 mg/mL, obtained from Streptococcus equi bacteria, with lidocaine hydrochloride 0.3%, sodium chloride 0.75%, disodium phosphate dodecahydrate 0.24%, sodium dihydrogen phosphate dihydrate 0.05% and BDDE cross-linking agent at 2 ppm or less, in water for injection, phosphate buffered at pH 6.7 to 7.3. Mean cross-linking degree 0.5 to 1.0%, typical particle size approximately 316 micrometres
Упаковка 1 pre-filled syringe x 1.0 mL with two 27G 1/2 inch needles, three patient record labels, an international implant card and a link to the patient information leaflet
Тип применения For professional use. Injectable dermal filler with anaesthetic
Объём / Размер 1 x 1 mL
Глубина введения Mid to deep dermis or submucosa
Протокол / Продолжительность For healthy adults, the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session

Показания и профессиональное применение

Основные показания

  • Moderate to severe nasolabial folds
  • Lip augmentation

Профессиональное применение

Saypha Filler Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

Зоны применения

  • Nasolabial folds, by mid to deep dermis injection
  • Lips, by submucosal injection

Профиль пациента

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

Как работает Saypha Filler Lidocaine ​

Saypha Filler Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the mid to deep dermis or the lip submucosa, where it adds volume to correct folds and augment the lip. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role to reduce pain and discomfort caused by the injection. It does not change how the gel behaves in tissue.

Почему стоит заказывать в Allpara

Allpara предлагает оригинальные проверенные продукты SAYPHA от проверенных поставщиков, с полной прослеживаемостью партий и экспертной поддержкой. Мы обслуживаем клиники и специалистов эстетической медицины: продукты с сертификатом CE, быстрая доставка по ЕС с нашего склада в ЕС и конкурентные оптовые цены. Наш приоритет - безопасность, удовлетворённость и результаты ваших пациентов, а также внимательная послепродажная поддержка для вашего спокойствия.

Часто задаваемые вопросы

How does Saypha Filler Lidocaine differ from the lidocaine-free Saypha Filler?

The gel concentration is the same at 23 mg/mL. This reference adds lidocaine hydrochloride 0.3% for injection comfort, and is indicated for nasolabial folds and lip augmentation with placement in the mid to deep dermis or submucosa. Where lidocaine is contraindicated, the plain Saypha Filler is the one to order.

How does it differ from Saypha Lips Lidocaine?

Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the needle.

Другие товары Croma-Pharma

View laboratory

SAYPHA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.

View SAYPHA products

POLYPHIL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.

View POLYPHIL products

Clinic alternatives

All products

Saypha Filler Lidocaine

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Saypha Filler Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, developed to correct moderate to severe nasolabial folds and for lip augmentation. It is suitable for practitioners and must be placed in the mid to deep dermis or submucosa. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate-buffered at pH 6.7 to 7.3, giving 2.3% sodium hyaluronate (equivalent to 23 mg/mL) with lidocaine HCl 0.3%, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

Ключевые преимущества Saypha Filler Lidocaine

  • Corrects moderate to severe nasolabial folds and augments the lips
  • Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
  • Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
  • Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
  • BDDE cross-linking agent present at 2 ppm or less
  • Steam sterilised in the syringe, which serves as the sterile barrier
  • Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
  • Manufactured by Croma-Pharma in Austria
Основная информация
Бренд SAYPHA
Производитель Croma-Pharma GmbH
Страна происхождения Austria
Сертификация CE marked 0123. The needles supplied are CE marked 0197
Состав Cross-linked sodium hyaluronate 2.3%, equivalent to 23 mg/mL, obtained from Streptococcus equi bacteria, with lidocaine hydrochloride 0.3%, sodium chloride 0.75%, disodium phosphate dodecahydrate 0.24%, sodium dihydrogen phosphate dihydrate 0.05% and BDDE cross-linking agent at 2 ppm or less, in water for injection, phosphate buffered at pH 6.7 to 7.3. Mean cross-linking degree 0.5 to 1.0%, typical particle size approximately 316 micrometres
Упаковка 1 pre-filled syringe x 1.0 mL with two 27G 1/2 inch needles, three patient record labels, an international implant card and a link to the patient information leaflet
Тип применения For professional use. Injectable dermal filler with anaesthetic
Объём / Размер 1 x 1 mL
Глубина введения Mid to deep dermis or submucosa
Протокол / Продолжительность For healthy adults, the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session

Показания и профессиональное применение

Основные показания

  • Moderate to severe nasolabial folds
  • Lip augmentation

Профессиональное применение

Saypha Filler Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

Зоны применения

  • Nasolabial folds, by mid to deep dermis injection
  • Lips, by submucosal injection

Профиль пациента

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

Как работает Saypha Filler Lidocaine ​

Saypha Filler Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the mid to deep dermis or the lip submucosa, where it adds volume to correct folds and augment the lip. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role to reduce pain and discomfort caused by the injection. It does not change how the gel behaves in tissue.

Почему стоит заказывать в Allpara

Allpara предлагает оригинальные проверенные продукты SAYPHA с полной прослеживаемостью партий, сертификатом CE, быстрой доставкой по ЕС и экспертной послепродажной поддержкой.

Часто задаваемые вопросы

How does Saypha Filler Lidocaine differ from the lidocaine-free Saypha Filler?

The gel concentration is the same at 23 mg/mL. This reference adds lidocaine hydrochloride 0.3% for injection comfort, and is indicated for nasolabial folds and lip augmentation with placement in the mid to deep dermis or submucosa. Where lidocaine is contraindicated, the plain Saypha Filler is the one to order.

How does it differ from Saypha Lips Lidocaine?

Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the needle.

Другие товары Croma-Pharma

Смотреть лабораторию →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.